Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

229 Views

Poster Session: Antimicrobial Novel Agents

1694 - Coadministration of Rezafungin Does Not Impact the Pharmacokinetics of Cyclosporine, Ibrutinib, Mycophenolate Mofetil, or Venetoclax

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

Shawn Flanagan, PhD

VP, Clinical Pharmacology and Early Development
Cidara Therapeutics
San Diego, California, United States
HW

Helen E. Walker, PhD

Clinical Pharmacologist
Mundipharma Research Limited
Nuneaton, England, United Kingdom
VO

Voon Ong, Executive Director

Executive Director, Preclinical Development
Cidara Therapeutics
San Diego, California, United States

Presenting Author(s)

Taylor Sandison, MD, MPH (he/him/his)

Chief Medical Officer
Cidara Therapeutics
San Diego, CA, United States